Bayer announced Thursday it has appointed Sebastian Guth as president of pharmaceuticals, Americas region, effective Dec. 1.
Bayer’s Americas region is comprised of the U.S., Canada, and Central and Latin America. Guth will be based in Whippany.
“Sebastian is a highly respected, seasoned leader in the pharmaceutical industry, and I’m thrilled to have him lead Bayer’s largest pharmaceutical business worldwide,” Dieter Weinand, member of Bayer’s board of management and president of pharmaceuticals, said. “Sebastian brings significant global experience gained from leadership roles in strategy, marketing, and business development and a proven track record of successful execution at the local level that will be crucial as we continue our growth in the U.S. and across the Americas region.”
Guth, who is currently a member of the company’s pharmaceutical executive committee, has been the executive vice president and chief marketing officer for Bayer’s global pharmaceutical business since October 2015. Before that, he was chief marketing officer for Bayer’s global general medicine business. Prior to that, CEO and president of Bayer Yakuhin Ltd., Osaka, leading Bayer’s health care business in Japan.
Guth began his career at Schering AG, where he held senior roles in Asia and the Middle East. He was later appointed head of strategy and business development for Schering’s European business. Following Bayer’s acquisition of Schering, he acted as CEO of Bayer Turk, Istanbul, and senior representative for the Bayer Group in Turkey.
